<h2 class="mt-4 text-lg font-medium text-color-lightgreytext" data-astro-cid-fjd3bvuv>
Summary from the AllSides News Team
</h2> <div class="mt-2 text-md editor-content" data-astro-cid-fjd3bvuv><p>The FDA approved a fourth dose of the <a href="/news/2022-03-14-1114/4th-dose-covid-19-vaccine-will-be-needed-pfizers-ceo-says-company-working-shot">Pfizer</a> and <a href="/news/2022-02-17-0518/moderna-ceo-sees-potential-end-coronavirus-pandemic-horizon-though-says-it-will">Moderna</a> COVID-19 vaccines for adults over 50.&nbsp;</p>

<p>The decision was announced Tuesday morning without consulting the agency’s <a href="/story/fda-panel-recommends-moderna-covid-19-vaccine">independent vaccine advisory committee</a>. Immunocompromised people will also be eligible for a second booster shot at age 12 for Pfizer and age 18 for Moderna. All patients must wait at least four months after their first booster to receive the second. Some reports said the CDC was expected to treat the second booster as optional rather than recommended. The FDA’s announcement came amid worries that <a href="/story/perspectives-global-implications-china-s-covid-19-outbreak">COVID-19 outbreaks in other countries</a> heralded an upcoming <a href="/news/2022-03-29-0638/omicron-stealth-covid-variant-ba2-now-dominant-globally">BA.2 “stealth omicron”</a> wave in the U.S.</p>

<p>Coverage was mostly balanced across the spectrum. While coverage was prominently featured in most major outlets across the spectrum, some right-rated outlets like <a href="/news-source/fox-news-media-bias">Fox News (Right)</a> and <a href="/news-source/new-york-post">New York Post (Lean Right)</a> did not appear to cover this story by Tuesday afternoon.&nbsp;</p>
</div> <h2 class="mb-2 leading-6 text-lg text-gray-500 font-medium mt-4 p-0">
Featured Coverage of this Story
</h2> <div class="flex gap-5 my-2 mb-8 md:flex-row flex-col"> <div class="flex-1 center"><div class="mb-2 font-bold border-solid global-bias-label text-color-center border-b-[3px] text-s border-color-center">From the Center</div><a id="News-Item--fda-green-lights-2nd-booster-of-pfizer-moderna-covid-shots-for-older-americans" href="https://www.reuters.com/world/us/fda-green-lights-second-booster-pfizerbiontech-moderna-covid-shot-older-2022-03-29/" target="_blank" rel="noopener"><div class="m-0 font-bold leading-tight text-md hover:underline text-base">FDA green lights 2nd booster of Pfizer, Moderna COVID shots for older Americans</div></a><div class="flex gap-2 items-center pt-2 hover:underline"><div class="overflow-hidden whitespace-nowrap"><p class="text-xs">Reuters</p></div><img src="https://img.allsides.com/sites/default/files/bias-center.png" alt="AllSides Media Bias Rating: Center" title="AllSides Media Bias Rating: Center" width="72" height="12" class="news-source-bias-image shrink-0" style="width: 72px !important; height: 12px !important; max-width: 72px !important;"><div class="flex-1 text-right ml-2 text-xs text-gray-500 underline whitespace-nowrap">
See rating details
</div></div><div class="mt-4"><div class="relative w-full"><img src="https://img.allsides.com/sites/default/files/7AYVU73CLVJB5M5E63CWIECYUA.jpg" alt="FDA green lights 2nd booster of Pfizer, Moderna COVID shots for older Americans" class="w-full h-auto object-cover"><div class="absolute bottom-0 left-0 right-0 h-12 bg-gradient-to-b from-color-transparent via-color-black/70 to-color-black px-1 pb-0 text-color-white flex items-end"><p class="text-xs pb-0.5">REUTERS/Emily Elconin</p></div></div></div><div class="mt-4"><div class="block text-xs leading-none mb-1 text-color-lightgreytext uppercase align-middle">News</div><div class="[&>p]:my-2 text-sm editor-content"><p>The U.S. Food and Drug Administration on Tuesday authorized a second booster dose for people age 50 and older of the two most commonly used COVID-19 vaccines, citing data showing waning immunity and the risks posed by Omicron variants of the virus.</p><p>Reporting by Michael Erman in New Jersey and Manojna Maddipatla in Bangaluru, Additional reporting by Ahmed Aboulenein in Washington; Editing by Bill Berkrot</p></div><a id="Open-On--reuters" class="text-xs inline-block border-b border-color-transparent no-underline font-bold whitespace-nowrap" href="https://www.reuters.com/world/us/fda-green-lights-second-booster-pfizerbiontech-moderna-covid-shot-older-2022-03-29/" target="_blank" rel="noopener">
Open on Reuters<i class="fa-regular fa-arrow-up-right-from-square ml-2"></i></a></div></div><script type="daed95bcf441396ebf9a0b22-module" src="/_astro/story-related-news.astro_astro_type_script_index_0_lang.DjPUAy8u.js"></script><div class="flex-1 left"><div class="mb-2 font-bold border-solid global-bias-label text-color-left border-b-[3px] text-s border-color-left">From the Left</div><a id="News-Item--fda-authorizes-2nd-covid-boosters-for-some-older-and-immunocompromised-people" href="https://www.npr.org/sections/health-shots/2022/03/27/1089072803/the-fda-is-expected-to-authorize-2nd-boosters-for-people-50-and-up" target="_blank" rel="noopener"><div class="m-0 font-bold leading-tight text-md hover:underline text-base">FDA authorizes 2nd COVID boosters for some older and immunocompromised people</div></a><div class="flex gap-2 items-center pt-2 hover:underline"><div class="overflow-hidden whitespace-nowrap"><p class="text-xs">NPR (Online News)</p></div><img src="https://img.allsides.com/sites/default/files/bias-leaning-left.png" alt="AllSides Media Bias Rating: Lean Left" title="AllSides Media Bias Rating: Lean Left" width="72" height="12" class="news-source-bias-image shrink-0" style="width: 72px !important; height: 12px !important; max-width: 72px !important;"><div class="flex-1 text-right ml-2 text-xs text-gray-500 underline whitespace-nowrap">
See rating details
</div></div><div class="mt-4"><div class="relative w-full"><img src="https://img.allsides.com/sites/default/files/Screenshot 2022-03-29 140102.jpg" alt="FDA authorizes 2nd COVID boosters for some older and immunocompromised people" class="w-full h-auto object-cover"><div class="absolute bottom-0 left-0 right-0 h-12 bg-gradient-to-b from-color-transparent via-color-black/70 to-color-black px-1 pb-0 text-color-white flex items-end"><p class="text-xs pb-0.5">FREDERIC J. BROWN/AFP via Getty Images</p></div></div></div><div class="mt-4"><div class="block text-xs leading-none mb-1 text-color-lightgreytext uppercase align-middle">News</div><div class="[&>p]:my-2 text-sm editor-content"><p>The Food and Drug Administration has authorized a second booster dose of either the Moderna or Pfizer-BioNtech COVID-19 vaccine for older people and certain immunocompromised individuals.</p><p>The second booster may be given to people who are 50 and older or immunocompromised at least four months after they received the first booster dose of any authorized or approved COVID vaccine. Immunocompromised people must be at least 12 to receive the 2nd Pfizer booster, and at least 18 to get the Moderna.</p><p>"Current evidence suggests some waning of protection over time against...</div><a id="Open-On--npr-online-news-" class="text-xs inline-block border-b border-color-transparent no-underline font-bold whitespace-nowrap" href="https://www.npr.org/sections/health-shots/2022/03/27/1089072803/the-fda-is-expected-to-authorize-2nd-boosters-for-people-50-and-up" target="_blank" rel="noopener">
Open on NPR (Online News)<i class="fa-regular fa-arrow-up-right-from-square ml-2"></i></a></div></div><div class="flex-1 right"><div class="mb-2 font-bold border-solid global-bias-label text-color-right border-b-[3px] text-s border-color-right">From the Right</div><a id="News-Item--fda-approves-second-booster-for-older-adults-some-immunocompromised-people" href="https://www.dailywire.com/news/fda-approves-second-booster-for-older-adults-some-immunocompromised-people" target="_blank" rel="noopener"><div class="m-0 font-bold leading-tight text-md hover:underline text-base">FDA Approves Second Booster For Older Adults, Some Immunocompromised People</div></a><div class="flex gap-2 items-center pt-2 hover:underline"><div class="overflow-hidden whitespace-nowrap"><p class="text-xs">The Daily Wire</p></div><img src="https://img.allsides.com/sites/default/files/bias-right-72x12.png" alt="AllSides Media Bias Rating: Right" title="AllSides Media Bias Rating: Right" width="72" height="12" class="news-source-bias-image shrink-0" style="width: 72px !important; height: 12px !important; max-width: 72px !important;"><div class="flex-1 text-right ml-2 text-xs text-gray-500 underline whitespace-nowrap">
See rating details
</div></div><div class="mt-4"><div class="relative w-full"><img src="https://img.allsides.com/sites/default/files/E00419ED-FF75-4C5C-BE5F-6652BA582522_1_201_a.jpeg" alt="FDA Approves Second Booster For Older Adults, Some Immunocompromised People" class="w-full h-auto object-cover"><div class="absolute bottom-0 left-0 right-0 h-12 bg-gradient-to-b from-color-transparent via-color-black/70 to-color-black px-1 pb-0 text-color-white flex items-end"><p class="text-xs pb-0.5">PeopleImages via Getty Images</p></div></div></div><div class="mt-4"><div class="block text-xs leading-none mb-1 text-color-lightgreytext uppercase align-middle">News</div><div class="[&>p]:my-2 text-sm editor-content"><p>On Tuesday, the U.S. Food and Drug Administration (FDA) authorized a second booster shot for adults 50 years of age and up for the Pfizer and Moderna COVID-19 vaccines, and for specific immunocompromised people in certain ways.</p><p>The FDA&nbsp;stated:&nbsp;</p><p>A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine or Moderna COVID-19 Vaccine may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine.</p><p>A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine...</div><a id="Open-On--the-daily-wire" class="text-xs inline-block border-b border-color-transparent no-underline font-bold whitespace-nowrap" href="https://www.dailywire.com/news/fda-approves-second-booster-for-older-adults-some-immunocompromised-people" target="_blank" rel="noopener">
Open on The Daily Wire<i class="fa-regular fa-arrow-up-right-from-square ml-2"></i></a><div class="flex-1 whitespace-nowrap text-gray-500 text-xs leading-4 flex mt-2"><div class="hover:cursor-help" data-tippy-content="<p><span style=&#34;white-space: nowrap;&#34;>Some content from this outlet may be</span><br><span style=&#34;white-space: nowrap;&#34;>limited or behind a paywall.</span></p>"><i class="fa-regular fa-sack-dollar mr-1"></i><span class="whitespace-nowrap">Possible Paywall</span></div></div></div></div> </div> <p class="mt-2 mb-5 text-right"> <a id="More-headline-roundups" class="group relative pr-5 hover:no-underline border-b border-opacity-0 hover:border-opacity-100 border-color-text inline-block w-fit cursor-pointer text-sm no-underline" href="/headline-roundups">